Barostat testing of rectal sensation and compliance in humans: Comparison of results across two centres and overall reproducibility

Neurogastroenterology and Motility

Volumn 17, Issue 6, 2005, Pages 810-820

  Cremonini, F ^a   Houghton, L A ^b   Camilleri, Michael ^a,f   Ferber, I ^a   Fell, C ^b   Cox, V ^b   Castillo, E J ^a   Alpers, D H ^c   Dewit, O E ^d   Gray, E ^d   Lea, R ^b   Zinsmeister, A R ^e   Whorwell, P J ^b  

^a Clinical Enteric Neuroscience Translational and Epidemiological Research Mayo Clinic   (United States)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Mayo Clinic   (United States)

^f MAYO CLINIC   (United States)

Author keywords

Ascending method of limits; Perception; Sensory ratings; Visceral

Indexed keywords

ABDOMINAL DISCOMFORT; ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ARTICLE; BAROSTAT; CALCULATION; CLINICAL TRIAL; COMPARATIVE ANATOMY; COMPLIANCE (PHYSICAL); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MULTICENTER STUDY; NORMAL HUMAN; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZATION; RATING SCALE; RECTUM; REPRODUCIBILITY; SAMPLE SIZE; SENSORY ANALYSIS; SYMPTOM; URGE INCONTINENCE;

ADULT; COMPLIANCE; ENDPOINT DETERMINATION; FEMALE; HUMANS; MALE; NEUROLOGIC EXAMINATION; PAIN MEASUREMENT; PRESSURE; RECTAL DISEASES; RECTUM; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SENSATION;

EID: 28544441071     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00709.x     Document Type: Article

References (37)

1. Lembo T, Munakata J, Mertz H et al. Evidence for the hypersensitivity of lumbar splanchnic afferents in irritable bowel syndrome. Gastroenterology 1994; 107: 1686-96.
2. Mertz H, Naliboff B, Munakata J, Niazi N, Mayer EA. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995; 109: 40-52.
3. Mearin F, Cucala M, Azpiroz F, Malagelada J-R. The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991; 101: 999-1006.
4. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001; 120: 652-68.
5. Whitehead WE, Delvaux M, The Working Team of Glaxo-Wellcome Research, UK. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. Dig Dis Sci 1997; 42: 223-41.
6. Microsoft, Inc. Microsoft Bookshelf Dictionary. Redmond, WA, USA: Microsoft, 1994.
7. Distrutti E, Azpiroz F, Soldevilla A, Malagelada J-R. Gastric wall tension determines perception of gastric distention. Gastroenterology 1999; 116: 1035-42.
8. Lembo T, Naliboff BD, Matin K et al. Irritable bowel syndrome patients show altered sensitivity to exogenous opioids. Pain 2000; 87: 137-47.
9. Sarnelli G, Vos R, Cuomo R, Janssens J, Tack J. Reproducibility of gastric barostat studies in healthy controls and in dyspeptic patients. Am J Gastroenterol 2001; 96: 1047-53.
10. Talley NJ, Phillips SF, Melton J III, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4.
11. Osman A, Breitenstein JL, Barrios FX, Gutierrez PM, Kopper BA. The fear of pain questionnaire III: further reliability and validity with nonclinical samples. J Behav Med 2002; 25: 155-73.
12. Taylor S, Cox BJ. An expanded Anxiety Sensitivity Index: evidence for a hierarchic structure in a clinical sample. J Anxiety Disord 1998; 12: 463-83.
13. Hammer HF, Phillips SF, Camilleri M, Hanson RB. Rectal tone, distensibility, and perception: reproducibility and response to different distensions. Am J Physiol 1998; 274: G584-90.
14. Ford MJ, Camilleri M, Zinsmeister AR, Hanson RB. Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon. Gastroenterology 1995; 109: 1772-80.
15. Bharucha AE, Camilleri M, Zinsmeister AR, Hanson RB. Adrenergic modulation of human colonic motor and sensory function. Am J Physiol 1997; 273: G997-G1006.
16. Delgado-Aros S, Chial HJ, Camilleri M et al. Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. Am J Physiol 2003; 284: G558-66.
17. Anonymous. The NLIN procedure. In: SAS/STAT User's Guide (version 6). Cary, NC, USA: SAS Inst, Inc., 1989: 1135-94.
18. Bouin M, Plourde V, Boivin M et al. Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds. Gastroenterology 2002; 122: 1771-7.
19. Bharucha AE, Seide B, Fox JC, Zinsmeister AR. Day-to-day reproducibility of anorectal sensorimotor assessments in healthy subjects. Neurogastroenterol Motil 2004; 16: 241-50.
20. Holtmann G, Goebell H, Talley NJ. Functional dyspepsia and irritable bowel syndrome: is there a common pathophysiological basis? Am J Gastroenterol 1997; 92: 954-9.
21. Hammonds R, Houghton LA, Whorwell PJ. Whole gut sensitivity in constipation predominant irritable bowel syndrome: 80 percent of patients exhibit an abnormality. Gastroenterology 1998; 114: 761.
22. Harraf F, Schmulson M, Saba L et al. Subtypes of constipation predominant irritable bowel syndrome based on rectal perception. Gut 1998; 43: 388-94.
23. Prior A, Maxton DG, Whorwell PJ. Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant subjects. Gut 1990; 31: 458-62.
24. Plourde V, Lembo T, Shui Z et al. Effects of the somatostatin analogue octreotide on rectal afferent nerves in humans. Am J Physiol 1993; 265: G742-51.
25. Lagier E, Delvaux M, Vellas B et al. Influence of age on rectal tone and sensitivity to distension in healthy subjects. Neurogastroenterol Motil 1999; 11: 101-7.
26. Sun WM, Read NW. Anorectal function in normal human subjects: effect of gender. Int J Colorectal Dis 1989; 4: 188-96.
27. Bradette M, Delvaux M, Staumont G, Fioramonti J, Bueno L, Frexinos J. Octreotide increases thresholds of colonic visceral perception in IBS patients without modifying muscle tone. Dig Dis Sci 1994; 39: 1171-8.
28. Naliboff BD, Munakata J, Fullerton S et al. Evidence for two distinct perceptual alterations in irritable bowel syndrome. Gut 1997; 41: 505-12.
29. Hammer J, Phillips SF, Talley NJ, Camilleri M. Effect of a 5HT3-antagonist (ondansetron) on rectal sensitivity and compliance in health and the irritable bowel syndrome. Aliment Pharmacol Ther 1993; 7: 543-51.
30. Czimmer J, Suto G, Kiraly A, Mozsik G. Otilonium bromide enhances sensory thresholds of volume and pressure in patients with irritable bowel syndrome. J Physiol Paris 2001; 95: 153-6.
31. Sabate JM, Gorbatchef C, Flourie B, Jian R, Coffin B. Cholecystokinin octapeptide increases rectal sensitivity to pain in healthy subjects. Neurogastroenterol Motil 2002; 14: 689-95.
32. Delvaux M, Beck A, Jacob J, Bouzamondo H, Weber FT, Frexinos J. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2004; 20: 237-46.
33. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin reuptake inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003; 1: 219-28.
34. Delvaux M, Louvel D, Mamet JP, Campos-Oriola R, Frexinos J. Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998; 12: 849-55.
35. van der Veek PP, Schots ED, Masclee AA. Effect of neurotensin on colorectal motor and sensory function in humans. Dis Colon Rectum 2004; 47: 210-8.
36. Law NM, Bharucha AE, Undale AS, Zinsmeister AR. Cholinergic stimulation enhances colonic motor activity, transit, and sensation in humans. Am J Physiol 2001; 281: G1228-37.
37. Thumshirn M, Coulie B, Camilleri M, Zinsmeister AR, Burton DD, Van Dyke C. Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2000; 14: 869-78.